关注
Antonella Cingolani
Antonella Cingolani
Università Cattolica S. Cuore - Fondazione Policlinico A. Gemelli IRCCS
在 unicatt.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ...
Nature medicine 27 (10), 1752-1760, 2021
4672021
Post-COVID-19 global health strategies: the need for an interdisciplinary approach
Aging clinical and experimental research 32 (8), 1613-1620, 2020
3332020
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ...
The lancet HIV 2 (3), e98-e106, 2015
3182015
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ...
Aids 16 (3), 369-379, 2002
3112002
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
2871997
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ...
Aids 15 (12), 1483-1491, 2001
2772001
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ...
The Lancet 399 (10339), 1941-1953, 2022
2562022
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2015
2202015
The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation …
LM Larocca, D Capello, A Rinelli, S Nori, A Antinori, A Gloghini, ...
Blood, The Journal of the American Society of Hematology 92 (3), 1011-1019, 1998
2191998
Patient-reported nonadherence to HAART is related to protease inhibitor levels
R Murri, A Ammassari, K Gallicano, A De Luca, A Cingolani, D Jacobson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (2), 123-128, 2000
2122000
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry …
A Antinori, A Cingolani, P Lorenzini, ML Giancola, I Uccella, S Bossolasco, ...
Journal of neurovirology 9, 47-53, 2003
2072003
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian …
A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ...
Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020
1992020
Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis
C Romagnoli, S Frezza, A Cingolani, A De Luca, M Puopolo, ...
European journal of pediatrics 160, 345-350, 2001
1992001
Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS …
A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ...
Journal of clinical oncology 17 (2), 554-554, 1999
1871999
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure
A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ...
AIDS research and human retroviruses 18 (12), 835-838, 2002
1842002
A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients
K Van Laethem, A De Luca, A Antinori, A Cingolani, CF Perno, ...
Antiviral therapy 7 (2), 123-129, 2002
1842002
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy
A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ...
Clinical infectious diseases 39 (11), 1681-1691, 2004
1742004
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis
A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ...
Aids 22 (14), 1759-1767, 2008
1712008
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy
A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ...
Neurology 55 (8), 1194-1200, 2000
1582000
Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent …
A Marzocchetti, S Di Giambenedetto, A Cingolani, A Ammassari, R Cauda, ...
Journal of clinical microbiology 43 (8), 4175-4177, 2005
1532005
系统目前无法执行此操作,请稍后再试。
文章 1–20